Cingulate CING
NASDAQ CING
$4.66 +0.13 (+2.87%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cingulate (CING) EPS (Diluted) (2022 - 2026)

Updated

Cingulate's EPS (Diluted) was -$0.45 in Q2 2026, compared with -$1.14 a year earlier.

Analysis

Cingulate (CING) EPS (Diluted) (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cingulate's EPS (Diluted) was -$1.86 through Jun 30, 2026; for FY2025, it came in at -$4.44.

  • In earlier years, EPS (Diluted) was -$10.86 in FY2024, -$312.00 in FY2023 and -$352.17 in FY2022.
  • The Q2 2026 figure marks the highest quarterly EPS (Diluted) in data going back to Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.94
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.27
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.04
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -0.54
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.67
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.60
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.37
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -8.44
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -0.04
10 Cingulate 61.34 Mn 6.35 Mn - -0.45
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.45
Dec 31, 2025 -1.24
Sep 30, 2025 -1.35
Jun 30, 2025 -1.14
Mar 31, 2025 -1.06
Dec 31, 2024 -4.09
Sep 30, 2024 -2.34
Jun 30, 2024 -5.51
Mar 31, 2024 -7.21
Dec 31, 2023 -91.93
Sep 30, 2023 -72.60
Jun 30, 2023 -135.79
Mar 31, 2023 -84.99
Dec 31, 2022 -91.75
Sep 30, 2022 -85.47
Jun 30, 2022 -85.75
API Access

Cingulate EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=CING&period=max&api_key=YOUR_API_KEY